Last updated on February 2018

Platine Avastin and OLAparib in 1st Line

Brief description of study

Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with Advanced FIGO Stage IIIB - IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer treated with standard First-Line Treatment, Combining Platinum-Taxane Chemotherapy and Bevacizumab Concurrent with Chemotherapy and in Maintenance.

Detailed Study Description

Patients with advanced FIGO stage IIIB - IV high grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer treated with standard first-line treatment, combining platinum-taxane chemotherapy and bevacizumab concurrent with chemotherapy and in maintenance.

Clinical Study Identifier: NCT02477644

Find a site near you

Start Over


Bad Homburg, Germany
  Connect »

Ortenau Klinikum

Offenburg, Germany
  Connect »


Copenhagen, Denmark
  Connect »

ICM Val d'Aurelle

Montpellier, France
  Connect »

amO Wolfsburg

Wolfsburg, Germany
  Connect »

Klinikum Aschaffenburg

Aschaffenburg, Germany
  Connect »

Centre Jean Perrin

Clermont-ferrand, France
  Connect »

CRLC Val d'Aurelle

Montpellier, France
  Connect »

Klinkum G tersloh

Gütersloh, Germany
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.